Bio
I graduated with a BSc Pharmacy (First Class Honors) degree before pursuing my graduate studies under the excellent tutelage of Professor Malcolm Stevens, inventor of temozolomide. This was followed by postdoctoral training at Stanford University, prior to embarking on liver cancer research in 2003, when I joined the Asian Liver Center’s comprehensive research program. I brought to it my broad expertise encompassing experimental therapeutics, oncology drug discovery and development, genomics, and molecular biology, which appropriately matches the goals of our research on developing diagnostic assays and therapeutic approaches for liver cancer.
Current Role at Stanford
I spearhead multiple projects stemming from the lab’s initial genomics study on liver cancer, with the goal of translating gene expression data of liver cancer patients into improved clinical approaches for the diagnosis and therapy of this fatal disease. I have successfully led inter-disciplinary projects, mentored postdoctoral fellows and visiting scientists, and effectively worked with diverse groups of collaborators from academic and industrial settings. I am committed to help eliminate global health care burden associated with hepatitis B and liver cancer.
